These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34285878)

  • 1. A case of secondary adrenocortical insufficiency due to isolated adrenocorticotropic hormone deficiency with empty sella syndrome after pembrolizumab treatment in a patient with metastatic renal pelvic cancer.
    Nagai T; Mogami T; Takeda T; Tomiyama N; Yasui T
    Urol Case Rep; 2021 Nov; 39():101766. PubMed ID: 34285878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pembrolizumab- and ipilimumab-induced diabetic ketoacidosis and isolated adrenocorticotropic hormone deficiency: a case report.
    Porntharukchareon T; Tontivuthikul B; Sintawichai N; Srichomkwun P
    J Med Case Rep; 2020 Sep; 14(1):171. PubMed ID: 32988414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature.
    Ohara N; Kobayashi M; Ohashi K; Ito R; Ikeda Y; Kawaguchi G; Yoneoka Y; Hasegawa G; Takada T
    J Med Case Rep; 2019 Mar; 13(1):88. PubMed ID: 30909965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pembrolizumab-Induced Hypophysitis With Isolated Adrenocorticotropic Hormone (ACTH) Deficiency: A Rare Immune-Mediated Adverse Event.
    Doodnauth AV; Klar M; Mulatu YS; Malik ZR; Patel KH; McFarlane SI
    Cureus; 2021 Jun; 13(6):e15465. PubMed ID: 34123679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case of Isolated Adrenocorticotropic Hormone Deficiency Caused by Pembrolizumab.
    Bekki T; Takakura Y; Kochi M; Konemori Y; Oki K; Yoneda M; Egi H; Ohdan H
    Case Rep Oncol; 2020; 13(1):200-206. PubMed ID: 32308578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of Empty Sella syndrome with adrenal insufficiency masked by prednisolone after administration of immune checkpoint inhibitors.
    Iwamoto Y; Tatsumi F; Ohnishi M; Katakura Y; Kimura T; Shimoda M; Nakanishi S; Mune T; Kaneto H
    Medicine (Baltimore); 2024 Mar; 103(10):e37204. PubMed ID: 38457550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated Adrenocorticotropic Hormone Deficiency Associated with Severe Hyperkalemia During Pembrolizumab Therapy in a Patient with Ureteral Cancer and an Ileal Conduit: A Case Report and Literature Review.
    Hinata Y; Ohara N; Sakurai Y; Koda R; Yoneoka Y; Takada T; Hara N; Nishiyama T
    Am J Case Rep; 2021 Jul; 22():e931639. PubMed ID: 34262010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. May primary empty sella turcica be a cause of isolated ACTH deficiency? A case report and the review of related literature.
    Gulcan E; Gulcan A; Taser F; Korkmaz U; Erbilen E
    Neuro Endocrinol Lett; 2007 Dec; 28(6):745-8. PubMed ID: 18063931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locally advanced endometrial cancer with multiple immune-related adverse events coinciding with the complete response to radiotherapy after immune checkpoint inhibitor therapy: A case report.
    Tanaka Y; Amano T; Takahashi A; Nishimura H; Yamanaka H; Yoneoka Y; Tsuji S; Murakami T
    Gynecol Oncol Rep; 2023 Oct; 49():101265. PubMed ID: 37705723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of Hypopituitarism and Hypothyroidism after Treatment with Pembrolizumab in a Patient with Adrenal Metastasis from Non-small-cell Lung Cancer.
    Yamagata S; Kageyama K; Takayasu S; Asari Y; Makita K; Terui K; Daimon M
    Intern Med; 2019 Dec; 58(24):3557-3562. PubMed ID: 31462588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pembrolizumab treatment of metastatic urothelial cancer without exacerbating myasthenia gravis.
    Ishii A; Yokoyama M; Tsuji H; Fujii Y; Tamaoka A
    eNeurologicalSci; 2020 Jun; 19():100236. PubMed ID: 32211521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiating Immune-Related Adrenal Insufficiency From Low Cardiac Output Syndrome: A Case Report.
    Tanabe J; Watanabe N; Ito M; Kanasaki K; Tanabe K
    Cureus; 2022 Nov; 14(11):e31349. PubMed ID: 36523682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyendocrinopathy Resulting From Pembrolizumab in a Patient With a Malignant Melanoma.
    Paepegaey AC; Lheure C; Ratour C; Lethielleux G; Clerc J; Bertherat J; Kramkimel N; Groussin L
    J Endocr Soc; 2017 Jun; 1(6):646-649. PubMed ID: 29264517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pembrolizumab-induced secondary adrenal insufficiency due to adrenocorticotrophic hormone deficiency in a patient with non-small-cell lung carcinoma: a case report.
    Fujimiya T; Azuma K; Togashi Y; Kuwata K; Unezaki S; Takeuchi H
    J Pharm Health Care Sci; 2024 Feb; 10(1):10. PubMed ID: 38365819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia gravis with myositis induced by pembrolizumab therapy in a patient with metastatic urothelial carcinoma.
    Hayakawa N; Kikuchi E; Suzuki S; Oya M
    Int Cancer Conf J; 2020 Jul; 9(3):123-126. PubMed ID: 32582515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metachronous immune-related adverse events involving type 1 diabetes and isolated adrenocorticotropic hormone deficiency associated with pembrolizumab monotherapy for metastatic head and neck cancer: a case report.
    Iijima H; Sakai A; Ebisumoto K; Yamauchi M; Teramura T; Yamazaki A; Inagi T; Okami K
    J Med Case Rep; 2023 Sep; 17(1):387. PubMed ID: 37697390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pembrolizumab-Induced Isolated Adrenocorticotropic Hormone (ACTH) Deficiency
.
    Alfares K; Han HJ
    Cureus; 2024 Jan; 16(1):e52235. PubMed ID: 38352096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary empty sella syndrome, ACTH hypersecretion, and normal adrenocortical function. Report of two cases.
    Sindler BH; Griffing GT; Melby JC
    Am J Med; 1982 Sep; 73(3):449-54. PubMed ID: 6289662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case of Lung Adenocarcinoma with Long-Term Response after Late-Onset Pembrolizumab-Induced Acute Adrenal Insufficiency.
    Sonehara K; Tateishi K; Hirabayashi T; Araki T; Ikuyama Y; Machida R; Hanaoka M
    Case Rep Oncol; 2021; 14(1):1-7. PubMed ID: 33613234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empty sella in children and adolescents with possible hypothalamic-pituitary disorders.
    Cacciari E; Zucchini S; Ambrosetto P; Tani G; Carlà G; Cicognani A; Pirazzoli P; Sganga T; Balsamo A; Cassio A
    J Clin Endocrinol Metab; 1994 Mar; 78(3):767-71. PubMed ID: 8126155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.